Prognosemarker nach TAVI

Donnerstag, 4. April | 14:30 - 16:00 Uhr | Posterbereich 16

Vorsitz/Chair: Kerstin Denise Piayda (Gießen), Madlen Uhlemann (Leipzig)


Monitoring of early hemodynamic changes after transcatheter aortic valve replacement using a wearable, non-invasive device
J. Hanisch (Düsseldorf)
Long-term outcomes of patient-prosthesis mismatch after transcatheter aortic valve implantation: A sub-analysis of the randomized SCOPE-1 trial
T. Rheude (München)
Epicardial Adipose Tissue as an Independent Predictor of Long-Term Outcome in Patients with Severe Aortic Stenosis undergoing Transcatheter Aortic Valve Replacement
A. Schulz (Göttingen)
Biatrial enlargement is associated with worse two-year outcome of patients undergoing transcatheter aortic valve implantation
A. Dormann (Würzburg)
Estimated glomerular filtration rate to haemoglobin ratio predicts two-year all-cause mortality in TAVI patients with preserved kidney function
J. Naß (Würzburg)
Fluoroscopy Guided (zero contrast) Transfemoral Aortic Valve Implantation WithoutPeriinterventional Transesophageal Echocardiography in Patients With Impaired Renal Function
O. Azizy (Bochum)
Evaluation of Post-TAVI Systemic Inflammatory Response: A Pathway to Rational Antibiotic Use
H. Guthoff (Köln)
Reclassification of Clinical Frailty Scale for a better prediction of two-year survival after Transcatheter Aortic Valve Implantation
L. Baez (Jena)
Diese Seite teilen